Spots Global Cancer Trial Database for cfdna
Every month we try and update this database with for cfdna cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Next-generation Sequencing in Gastrointestinal Cancer | NCT03476057 | Gastrointestina... | Device： NGS seq... | - | Fujian Cancer Hospital | |
| Detection of Aneuploidy in Cell Free DNA to Improve the Sensitivity of Diagnostic Peritoneal Lavage in Gastric Cancer | NCT06308510 | Gastric Cancer | collection addi... | 18 Years - | Erasmus Medical Center | |
| Concordance Between ctDNA Assay and FoundationOne | NCT02620527 | Circulating Tum... Cancer Neoplasms Genomic Testing Genomic Alterat... | 18 Years - | Foundation Medicine | ||
| Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA | NCT04264767 | Cancer Solid Tumor Hematologic Neo... | Blood collectio... | 22 Years - 80 Years | Nucleix Ltd. | |
| Cell-free DNA From Junction of Hepatitis B Virus Integration in HCC Patients for Monitoring Post-resection Recurrence | NCT05823584 | Hepatocellular ... | 20 Years - | TCM Biotech International Corp. | ||
| Plasma cfDNA Testing Guiding the Treatment Decisions of DLBCL | NCT06289959 | Lymphoma, Large... | cfDNA | 18 Years - | Second Affiliated Hospital of Soochow University | |
| Analysis of cfDNA in Patients With Hepatocarcinoma and Treated by Sorafenib or Regorafenib | NCT03956940 | Hepatocarcinoma | Intplex test | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Project CADENCE (CAncer Detected Early caN be CurEd) | NCT05633342 | Thoracic Cancer Ovarian Cancer Liver Cancer Prostate Cancer Gastric Cancer Colorectal Canc... Breast Cancer Esophageal Canc... Pancreatic Canc... | 21 Years - | MiRXES Pte Ltd | ||
| Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA | NCT04264767 | Cancer Solid Tumor Hematologic Neo... | Blood collectio... | 22 Years - 80 Years | Nucleix Ltd. | |
| Characterization & Comparison of Drugable Mutations in Primary and Metastatic Tumors, CTCs and cfDNA in MBCpatients | NCT02626039 | Metastatic Brea... | 18 Years - | Hospital General Universitario Gregorio Marañon | ||
| LIQUIK: LIQUId Biopsy for Detection of Actionable Genomic BiomarKers in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) | NCT04703153 | Non Small Cell ... | 21 Years - | Lucence Health Inc. | ||
| Evaluation of cfDNA as a Marker of Response in Rectal Cancer | NCT04319354 | Cancer of Rectu... | Analysis of cfD... | 18 Years - | Hospital Pedro Hispano | |
| Whole-body DW-MRI and cfDNA Analysis for the Surveillance of Melanoma Patients at High Risk for Recurrence. | NCT02907827 | Melanoma | follow up DW MR... | 18 Years - | Universitair Ziekenhuis Brussel | |
| Next-generation Sequencing in Gastrointestinal Cancer | NCT03476057 | Gastrointestina... | Device： NGS seq... | - | Fujian Cancer Hospital | |
| Analysis of cfDNA in Patients With Hepatocarcinoma and Treated by Sorafenib or Regorafenib | NCT03956940 | Hepatocarcinoma | Intplex test | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Assessement of the Concordance of Genomic Alterations Between Urine and Tissue in High-Risk NMIBC Patients | NCT04412070 | Bladder Cancer | 18 Years - | Hopital Foch | ||
| Detection of Tumor DNA in Blood Samples From Cancer Patients | NCT02288754 | Cancer Tumors | Blood test | 18 Years - | Lexent Bio, Inc. | |
| Detection of Tumor DNA in Blood Samples From Cancer Patients | NCT02288754 | Cancer Tumors | Blood test | 18 Years - | Lexent Bio, Inc. | |
| ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer | NCT03903835 | Metastatic Cast... Metastatic Horm... | Enzalutamide Or... Abiraterone Ora... Carboplatin Cabazitaxel 60 ... Docetaxel Injec... Radium Chloride... Niraparib plus ... Capivasertib pl... Apalutamide Darolutamide | 18 Years - | Karolinska Institutet | |
| Assessement of the Concordance of Genomic Alterations Between Urine and Tissue in High-Risk NMIBC Patients | NCT04412070 | Bladder Cancer | 18 Years - | Hopital Foch | ||
| Characterization & Comparison of Drugable Mutations in Primary and Metastatic Tumors, CTCs and cfDNA in MBCpatients | NCT02626039 | Metastatic Brea... | 18 Years - | Hospital General Universitario Gregorio Marañon | ||
| Development and Validation of Harbinger Health Test for Early Cancer Detection | NCT05435066 | Cancer | Harbinger Healt... | 20 Years - 79 Years | Harbinger Health | |
| Analysis of cfDNA in Patients With Hepatocarcinoma and Treated by Sorafenib or Regorafenib | NCT03956940 | Hepatocarcinoma | Intplex test | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
| Exploring a Breast Cancer Early Screening Model Based on cfDNA | NCT06016790 | Breast Cancer Breast Fibroade... Breast Hypoplas... | cfDNA sequencin... | 18 Years - 70 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
